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Gallbladder stoneAbstract Gallbladder (GB) stones have been associatedwith severalmetabolic factors and liver
diseases. This community-based study aimed at investigating the prevalence rate of GB stones
and its associated factors in a hepatitis B virus (HBV)/hepatitis C virus (HCV)-endemic township
in southern Taiwan. A total of 1701 residents (689 males and 1012 females; mean age:
51.2  16.0 years) were enrolled in this prospectively designed screening project. Serum
biochemistry tests, including testing for levels of serum aspartate aminotransferase, alanine
aminotransferase (ALT), hepatitis B surface antigen (HBsAg), and antibody to HCV (anti-HCV)
were conducted. In addition, a hepatobiliary ultrasonographic (US) examination was also con-
ducted. Of the 1701 residents, 243 (14.3%) and 475 (27.9%) were found to be positive for HBsAg
and anti-HCV, respectively. Results of the US examination revealed the prevalence rate of GB
stone and fatty liver to be 6.8% and 55.6%, respectively. Using univariate analyses we found that
significantly higher proportions of the participants with GB stoneweremale, over 50 years of age,
positive for anti-HCV (pZ 0.001, p< 0.001, and pZ 0.001, respectively), with significantly high-
er mean age and ALT level (p  0.001 and pZ 0.048, respectively) than did those without GB
stone. By applying multivariate analyses, male gender, positive anti-HCV, and older age (>50
year) were identified as independent factors associated with the formation of GB stones. Anti-
HCVwas associatedwith GB stones inmales but not in females in both univariate andmultivariate
analyses. GB stones were found to have a prevalence rate of 6.8% in this HCV/HBV hyperendemic
township and are associatedwith highermean age. A correlation between chronic hepatitis C and
GB stones is observed only among males.
Copyright ª 2012, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Ultrasonography (US) is a noninvasive tool for evaluating
disorders of the internal organs. Because of its extensive
application in the clinical diagnosis of abdominal diseases,
diagnosis of gallbladder (GB) stones and polyps is common
in US examinations [1,2]. The criteria for diagnosing GB
stones are the presence of echogenic densities casting
distal acoustic shadow or mobility upon postural change
with or without distal acoustic shadow [3,4]. The risk of GB
stones has been reported to increase in patients with
chronic liver disease, particularly liver cirrhosis [5,6], while
metabolic factors such as lipid profile, obesity, or abnormal
glucose levels have also been reported to be associated
with increases in the risk level [7e9].
Taiwan is a country endemic for hepatitis B virus (HBV).
Results of recent reports suggest that the prevalence rate
of hepatitis B surface antigen (HBsAg) is approximately
14e17% in adults [10e12]. The prevalence rate of anti-
body to hepatitis C virus (anti-HCV) is approximately
3e4%, with higher rates reported in southern Taiwan
[10e12]. Several HCV hyperendemic townships have been
discovered, with anti-HCV present in more than 20% of the
adult population [13e15]. Tzukuan Township is one such
area, with a previous study reporting an anti-HCV preva-
lence rate of 39.2% [16]. The impact of chronic hepatitis
on GB stones and the relationship between metabolic
factors and GB stones warrant further evaluation. This
community-based study aimed at investigating the prev-
alence rate of GB stones and its associated factors in an
HBV/HCV-endemic township in southern Taiwan based on
a screening project.Patients and methods
A prospective survey of liver diseases in the Tzukuan
Township of Kaohsiung County on the southern coast of
Taiwan was conducted. Adult residents were invited to
participate in laboratory tests and abdominal US examina-
tion, with a 12-hour overnight fasting before the tests.
Serum aspartate aminotransferase (AST), alanine
aminotransferase (ALT), fasting plasma glucose (FPG),
triglycerides, and total cholesterol (TC) levels were
measured on a multichannel auto-analyzer (Hitachi Inc.,
Tokyo, Japan). HBsAg and anti-HCV antibody were detected
using a third-generation, commercially available enzyme-
linked immunosorbent assay kit (AxSYM 3.0; Abbott Labo-
ratories, Chicago, IL, USA). Experienced hepatologists from
Kaohsiung Medical University Hospital, a medical center in
Kaohsiung City, performed the US examination using a 3.5-
MHz convex transducer (Toshiba SSA-250; Toshiba, Tokyo,
Japan). To minimize interobserver differences, training for
standardized diagnosis in US was conducted for doctors.
In the US findings, GB stone was diagnosed by movable
hyperechoic contents in the GB lumen with or without
acoustic shadows. The diagnosis of fatty liver (FL) was based
on the brightness of the liver on US compared with the
kidneys, deep attenuation in the right hepatic lobe, and
vascular blurring of the hepatic vein trunk, while the
severity of FL change was classified according to standard-
ized US criteria with somemodification: normal liver, normal
echo texture, and absence of fatty change; mild FL, mild
increase in fine echoes, and attenuation of the lower fourth
of the screen in the parenchyma with slightly impaired
visualization of the intrahepatic vessels and diaphragm;
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tion of the lower half of the screen in the parenchyma with
poor visualization of the intrahepatic vessel borders, dia-
phragm, and posterior right lobe of the liver; severe FL,
marked increase in fine echoes, and attenuation of the more
than lower half of the screen in the parenchyma with non-
visualization of the intrahepatic vessel borders, diaphragm,
and posterior right lobe of the liver [17,18]. Body mass index
(BMI) was calculated as weight per height squared (kg/m2).Statistical analysis
The frequency of GB was compared between groups using
the Chi-square test with Yate correction or Fisher exact
test. Group means were compared using Student t test,
while stepwise logistic regression method was used as
appropriate. A two-tailed p < 0.05 was considered to be
statistically significant. The procedures were performed
using the SPSS version 12.0 statistical package (SPSS Inc.,
Chicago, IL, USA).Results
A total of 1701 participants were enrolled, including 243
(14.3%) and 475 (27.9%) who were positive for HBsAg and
anti-HCV, respectively, and 49 (2.9%) who were positive for
both. Results of US examination revealed the prevalence
rates of the GB stones and FL to be 6.8% (115) and 55.6%
(156), respectively (Table 1).Table 1 Basic characteristics of the study participants
(n Z 1701).
Factors N (%)
Gender (male/female) 689/1012
Age (y) 51.2  16.0
>50 y 917 (53.9)
Body mass index (kg/m2) 24.1  3.9
AST (U/L) 28.8  21.6
ALT (U/L) 27.9  26.8
Positive HBsAg 243 (14.3)
Positive anti-HCV 475 (27.9)
Fasting plasma sugar (mg/dL) 92.4  29.7
Triglycerides (mg/dL) 115.1  79.2
Cholesterol (mg/dL) 192.1  37.2
Ultrasonographic diagnosis
With gallstone 115 (6.8)
With gallbladder polyp 100 (5.9)
Fatty livera
No 756 (44.4)
Mild 579 (34.0)
Moderate 297 (17.5)
Severe 69 (4.1)
Data are presented as mean  standard deviation or n (%).
ALT Z alanine aminotransferase; AST Z aspartate amino-
transferase; GB Z gallbladder; HBsAg Z hepatitis B surface
antigen; HCV Z hepatitis C virus.
a The severity of fatty liver was classified according to stan-
dardized ultrasonographic criteria mentioned in text.The clinical factors between participants with and those
without GB stones were compared (Table 2). Using univar-
iate analyses we found that significantly higher proportions
of residents with GB stones were males (pZ 0.001), aged >
50 years (p < 0.001), and positive for anti-HCV (pZ 0.001),
with significantly higher mean age (p < 0.001) and ALT
levels (p Z 0.048) than those without GB stones. The
presence of GB stones was not associated with HBsAg
positivity, mean BMI, AST, FPG, triglycerides, and TC levels,
as well as severity of FL. Using multivariate analyses, male
gender, positivity for anti-HCV, and higher mean age were
found to be independent factors associated with GB stones
[odds ratios (OR) and 95% confidence intervals (CI) are
shown in Table 3].
The relationship between anti-HCV and GB stones was
further evaluated for male and female participants (Table
2). Among the male residents, those with GB stones had
significantly higher frequency of positive anti-HCV
(p < 0.001) and significantly higher mean age (p < 0.001)
in univariate analyses. Among the female residents, those
with GB stones had significantly higher proportion of age
>50 years (p < 0.001) and higher mean age (pZ 0.003), but
were not positive for anti-HCV in univariate analyses.
Clinical factors among the 475 anti-HCV-positive
participants with and without GB stones were compared
(Table 4). Significantly higher proportions of participants
with GB stones were males (p Z 0.001). Using multivariate
analyses, we found that positive anti-HCV was an inde-
pendent factor associated with GB stones in males but not
in females (OR and 95% CI shown in Table 3).Discussion
In the present study, the prevalence rates of HBV and HCV
infection were 19.2% and 33.5%, respectively, confirming
that Tzukuan Township is an HBV- and HCV-endemic
community. In this community-based study using US, the
prevalence rates of gallstones and FL were 6.8% and 55.6%,
respectively. To date, this is the first community-based
report on the association between clinical factors,
including chronic viral hepatitis, and GB stones in an HBV/
HCV hyperendemic area. The results demonstrated that
gender, positivity for anti-HCV, and higher mean age were
independent factors associated with GB stones. Further-
more, the link between chronic hepatitis C and GB stones
was observed only among males.
Chronic hepatic inflammation has been recognized as
one of the causes of GB stone formation [1]. Increased
prevalence of GB stones has been reported in patients with
chronic HCV infection [5,19]. Acalovschi et al. in their
hospital-based study reported that HCV infection was a risk
factor for GB stones when comparing CHC patients and
controls without liver diseases [9]. With the present
community-based report in an HBV/HCV hyperendemic
area, an association between GB stones and chronic HCV
infection, but not HBV infection, was shown.
The mechanisms of HCV infection on GB stone formation
remain undetermined. Uchida et al. have previously re-
ported that HCV core antigen can be demonstrated by
immunoperoxidase staining in proliferated bile duct
epithelia [20], while Loriot et al. have shown that HCV RNA
Table 2 Comparison of clinical characteristics between individuals with and those without GB stone.
GB stone p GB stone p GB stone p
Positive (n Z 115) Negative (n Z 1586) Positive (n Z 64) Negative (n Z 625) Positive (n Z 51) Negative (n Z 961)
All, n Z 1701 Male, n Z 689 Female, n Z 1012
Male 64 (55.7) 625 (39.4) 0.001 d d d d
Age (years) 58.8  13.8 50.7  16.0 <0.001 60.8  14.4 51.1  17.1 <0.001 56.1  12.7 50.4  15.3 0.003
>50 years 86 (74.8) 831 (52.4) <0.001 49 (76.6) 326 (52.2) 0.005 37 (72.5) 505 (52.6) <0.001
Body mass index (kg/m2) 24.6  3.7 24.1  4.0 0.235 24.5  3.6 24.6  3.8 0.807 24.6  4.0 23.7  4.0 0.144
AST (U/L) 32.0  18.7 28.6  21.8 0.103 33.4  19.2 31.2  25.7 0.488 30.4  18.1 26.9  18.5 0.183
ALT (U/L) 32.8  29.8 27.6  26.5 0.048 35.4  30.3 32.6  30.4 0.523 29.5  29.1 24.3  23.4 0.126
HBsAg 12 (10.4) 231 (14.6) 0.222 5 (7.8) 96 (15.4) 0.136 7 (13.7) 135 (14.0) 0.948
Anti-HCV 48 (41.7) 427 (26.9) 0.001 29 (45.3) 149 (23.8) <0.001 19 (37.3) 278 (28.9) 0.203
Fasting plasma sugar 95.1  31.2 92.2  29.6 0.339 94.9  25.4 94.3  35.6 0.913 95.5  38.0 90.9  24.9 0.250
Triglycerides (mg/dL) 112.3  57.0 115.4  80.7 0.707 118.5  62.3 129.8  92.7 0.358 103.9  48.3 106.3  70.7 0.802
Cholesterol (mg/dL) 188.9  36.2 192.4  37.3 0.353 185.3  35.8 187.3  35.6 0.672 193.8  36.5 195.6  38.0 0.766
Ultrasonographic finding
Gallbladder polyp 8 (7) 92 (5.8) 0.611 8 (12.5) 49 (7.8) 0.229 0 (0) 43 (4.5) 0.123
Fatty livera
No 46 (40) 710 (44.8) 0.278 25 (39.1) 262 (41.9) 0.393 21 (41.2) 448 (46.6) 0.685
Mild 38 (33) 541 (34.1) 20 (31.3) 215 (34.4) 18 (35.3) 326 (33.9)
Moderate 28 (24.3) 269 (17) 17 (26.6) 1149 (18.2) 11 (21.6) 155 (16.1)
Severe 3 (2.6) 66 (4.2) 2 (3.1) 34 (5.4) 1 (2.0) 32 (3.3)
Data are presented as mean  standard deviation or n (%).
ALT Z alanine aminotransferase; AST Z aspartate aminotransferase; GB Z gallbladder; HBsAg Z hepatitis B surface antigen; HCV Z hepatitis C virus.
a The severity of fatty liver was classified according to standardized ultrasonographic criteria mentioned in text.
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Table 3 Multivariate logistic regression analysis of factors significantly associated with GB stones and GB polyps.
Variable Independent
factor
Comparison Odds ratio (95% CI) p
GB stone presence (n Z 1701)
Gender Female Z 0, Male Z 1 1.972 (1.341e2.898) 0.001
Anti-HCV Negative Z 0, Positive Z 1 1.539 (1.023e2.317) 0.039
Age 50 years Z 0, >50 years Z 1 2.360 (1.499e3.714) <0.001
GB stone presence (male, n Z 689)
Anti-HCV Negative Z 0, Positive Z 1 2.021 (1.146e3.508) 0.012
Age 50 years Z 0, >50 years Z 1 2.421 (1.293e4.535) 0.006
GB stone presence (female, n Z 1012)
Age 50 years Z 0, >50 years Z 1 2.230 (1.194e4.439) 0.013
CI Z confidence interval; GB Z gallbladder; HCV Z hepatitis C virus.
434 C.-Y. Dai et al.can be detected in GB cell culture [21]. Recently, the
association between HCV and cholangiocarcinoma has been
suggested, based on the results US examinations [22,23].
Thus, HCV may alter GB function, which may contribute to
the development of GB stones. Furthermore, HCV infection
has an impact on metabolic derangements resulting from its
interaction with lipid and glucose metabolisms [24e27]. It
is possible that HCV infection alters bile composition, which
facilitates and contributes to the formation of GB stonesTable 4 Comparison of clinical characteristics between
anti-HCV-positive individuals with GB stone and individuals
without GB stone.
GB stone p
Positive
(n Z 48)
Negative
(n Z 427)
Male gender 29 (60.4) 149 (34.9) 0.001
Age (year) 62.3  12.2 60.0  12.5 0.237
>50 years 40 (83.3) 339 (79.4) 0.519
Body mass index
(kg/m2)
24.0  3.9 24.6  3.7 0.299
AST (U/L) 43.0  23.7 39.0  28.2 0.356
ALT (U/L) 47.4  41.18 39.1  35.0 0.139
HBsAg 3 (6.3) 46 (10.8) 0.455
Fasting plasma
sugar
101.7  42.7 96.3  34.6 0.348
Triglycerides
(mg/dL)
105.5  62.7 107.9  69.2 0.827
Cholesterol
(mg/dL)
181.1  36.7 186.1  38.3 0.418
Ultrasonographic finding
Fatty livera
No 24 (50) 193 (45.2) 0.937
Mild 16 (33.5) 155 (36.3)
Moderate 7 (14.6) 68 (15.9)
Severe 1 (2.1) 11 (2.6)
Data are presented as mean  standard deviation or n (%).
ALT Z alanine aminotransferase; AST Z aspartate amino-
transferase; GB Z gallbladder; HBsAg Z hepatitis B surface
antigen; HCV Z hepatitis C virus.
a The severity of fatty liver was classified according to stan-
dardized ultrasonographic criteria mentioned in text.[28]. Nonetheless, the actual pathophysiology of HCV
infection causing GB stones requires further investigation.
In the present study, old age was an independent factor
associated with GB stones, which was similar to reports by
Chang et al. [19], who showed that the prevalence of
gallstones positively correlated with increasing age in anti-
HCV-positive, HBsAg-positive, and both anti-HCV and
HBsAg-negative patients groups. Furthermore, the associ-
ation between HCV infection and GB stones existed in males
but not in females, which is the first such report. The
reasons for the different gender effects of HCV infection on
GB stone formation remain unclear. While female gender
has been associated with higher prevalence of GB stones in
previous studies [9,19], in this study, there was a lower
prevalence of gallstones among females in a hepatitis-
endemic community. Whether the minimal impact of HCV
infection on female gender can be attributed to a lower risk
of GB stones in females also warrants further evaluation.
In conclusion, the present community-based study
reveals that the prevalence rates of positive anti-HCV,
positive HBsAg, and presence of GB stones and FL were
27.9%, 14.3%, 6.8%, and 55.6%, respectively in an HCV/HBV
hyperendemic township. The presence of GB stones was
associated with older age and chronic HCV, but not with
HBV, infection in males.Acknowledgments
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